Università LUM Giuseppe Degennaro - sito della Ricerca Institutional Research Information System

LEGGE, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.590
AS - Asia 1.229
EU - Europa 261
AF - Africa 117
SA - Sud America 71
OC - Oceania 2
Totale 3.270
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.560
SG - Singapore 703
CN - Cina 383
MA - Marocco 110
DE - Germania 93
BR - Brasile 53
PK - Pakistan 36
IT - Italia 31
VN - Vietnam 25
HK - Hong Kong 24
FR - Francia 23
PL - Polonia 23
GB - Regno Unito 21
NL - Olanda 20
BD - Bangladesh 13
CA - Canada 11
CZ - Repubblica Ceca 11
JP - Giappone 10
IN - India 9
MX - Messico 9
ES - Italia 7
LT - Lituania 6
TR - Turchia 6
UA - Ucraina 6
EC - Ecuador 5
FI - Finlandia 5
JM - Giamaica 5
SE - Svezia 5
ID - Indonesia 4
AR - Argentina 3
EG - Egitto 3
VE - Venezuela 3
ZA - Sudafrica 3
AM - Armenia 2
AZ - Azerbaigian 2
CO - Colombia 2
HR - Croazia 2
PT - Portogallo 2
RU - Federazione Russa 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AT - Austria 1
AU - Australia 1
BO - Bolivia 1
BS - Bahamas 1
CH - Svizzera 1
CL - Cile 1
CR - Costa Rica 1
GR - Grecia 1
HN - Honduras 1
IL - Israele 1
IQ - Iraq 1
JO - Giordania 1
MD - Moldavia 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
PE - Perù 1
PH - Filippine 1
PR - Porto Rico 1
PW - Palau 1
PY - Paraguay 1
TJ - Tagikistan 1
TL - Timor Orientale 1
TN - Tunisia 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 3.270
Salva come PNG Salva come JPEG
Città #
San Jose 451
Dallas 356
Singapore 318
Ashburn 259
The Dalles 127
Hefei 121
Casablanca 107
Munich 72
Islamabad 36
Chicago 32
Los Angeles 26
Hillsboro 25
Hong Kong 24
Santa Clara 22
Warsaw 22
New York 20
Council Bluffs 17
Atlanta 16
Beijing 16
Amsterdam 14
Frankfurt am Main 13
Ho Chi Minh City 10
Orem 10
Tokyo 10
Boston 9
Brno 9
London 9
Brooklyn 8
San Francisco 8
Reston 7
Boydton 6
Mexico City 6
Phoenix 6
São Paulo 6
Chennai 5
Stockholm 5
Bari 4
Charlotte 4
Milan 4
Rome 4
Ankara 3
Clifton 3
Denver 3
Guayaquil 3
Haiphong 3
Kingston 3
Marrakesh 3
Paris 3
Poplar 3
Seattle 3
Toronto 3
Turku 3
Baku 2
Barnet 2
Biên Hòa 2
Bogotá 2
City of London 2
Cuiabá 2
Hanoi 2
Johannesburg 2
Kansas City 2
Limburg an der Lahn 2
Miami 2
Montreal 2
Olomouc 2
Queens 2
St Petersburg 2
Tappahannock 2
Yerevan 2
Zagreb 2
Ahmedabad 1
Alexandria 1
Alfenas 1
Allen 1
Allentown 1
Amman 1
Angri 1
Aracruz 1
Arapoti 1
Araxá 1
Arujá 1
Aston Mills 1
Athens 1
Baoding 1
Bayonne 1
Belchertown 1
Berkeley 1
Betânia do Piauí 1
Bismarck 1
Botucatu 1
Brownsville 1
Buenos Aires 1
Burlington 1
Cabimas 1
Cabreúva 1
Cagliari 1
Cairo 1
Calamba 1
Calgary 1
Campinas 1
Totale 2.326
Salva come PNG Salva come JPEG
Nome #
Biologia e genetica molecolare in ginecologia ed ostetricia 49
Celecoxib modulates the expression of cyclooxygenase-2, Ki67, apoptosis-related marker, and microvessel density in human cervical cancer: A pilot study 48
A case of drug resistant clear cell ovarian cancer showing responsiveness to gemcitabine at first administration and at re-challenge 47
Carboplatin (C) plus paclitaxel (P) versus carboplatin plus pegylated liposomal doxorubicin (PLD) in patients with advanced ovarian cancer (AOC): final analysis of the MITO-2 randomized multicenter trial 44
Analysis of survivin expression in ovarian cancer and its correlation with clinical, surgical, pathological and apoptosis-related parameters 44
BRCA1-related malignancies in a family presenting with von Recklinghausen's disease 44
Angiogenesis inhibitors in gynecological cancers 43
Carboplatin (C) plus paclitaxel (P) versus carboplatin plus pegylated liposomal doxorubicin (PLD) as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III 43
Advances in surgical management of cervical cancer 42
Preoperative concomitant chemoradiotherapy in locally advanced cervical cancer: Safety, outcome, and prognostic measures 41
Celecoxib plus carboplatin in heavily pre-treated patients with recurrent ovarian carcinoma: preliminary results of a phase II study 41
[Familial ovarian carcinoma] 40
Analysis of cyclooxygenase-2 (COX-2) expression in different sites of endometriosis and correlation with clinicopathological parameters 39
Anatomical distribution of sentinel lymph nodes in patients with endometrial cancer: a multicenter study 39
Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study 38
[Biological factors with prognostic significance in ovarian cancer]. Fattori biologici con significato prognostico nel cancro ovarico 38
Biological characterization of ovarian cancer: prognostic and therapeutic implications 37
Biologia e genetica molecolare in ginecologia ed ostetricia 37
Ruolo dell'isterectomia laparoscopica nel trattamento del carcinoma della cervice uterina 36
Celecoxib modulates angiogenesis-related parameters in both sera and tumor biopsies from cervical cancer patients 36
A prospective multicentric study of risk-reducing salpingo-oophorectomy in BRCA mutation patients 36
Tumori maligni della cervice uterina 34
Tumori maligni della cervice uterina 34
Whose surgery is this? Endometriosis of the round ligament 33
Magnetic resonance imaging of pelvic endometriosis. Effect of reader's experience on accuracy and interobserver variability 33
Impact of pattern of recurrence on clinical outcome of ovarian cancer patients: Clinical considerations 33
Cyclooxygenase-2 (COX-2) expression in non neoplastic (NNED) and  neoplastic vulvar epithelial disorders 33
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 33
Clinical outcome of recurrent endometrial cancer: analysis of post-relapse survival by pattern of recurrence and secondary treatment 33
Cyclooxygenase-2 (COX-2) inhibition is associated with increased proportion of Tumor Infiltrating Lymphocytes (TIL) expressing the zeta chain of T-Cell Receptor (TCR) in human cervical cancer 33
Definition of a dynamic laparoscopic model for the prediction of incomplete cytoreduction in advanced epithelial ovarian cancer: proof of a concept 31
Prognostic role of the ratio between cyclooxygenase-2 (COX-2) in tumor and stroma compartments in cervical cancer 31
Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcome 31
Robotic Surgery in Elderly and Very Elderly Gynecologic Cancer Patients 31
Cyclooxygenase-2 expression in endometrial carcinoma - Correlation with clinicopathologic parameters and clinical outcome 30
Targeted therapy for ovarian cancer 30
Transplacental carcinogenesis: state of the art 30
Comparison of Different Surgical Approaches for Stage IB1 Cervical Cancer Patients: A Multi-institution Study and a Review of the Literature 30
Intensified pre-operative chemoradiation in locally advanced carcinoma of the uterine cervix: final resultsof a phase I-II study (ESTER-1) 29
Large-field pre-operative chemoradiation in locally advanced carcinoma of the cervix: preliminary results of a phase I study (LARA-CC-1) 29
Expression of cyclooxygenase-2 (COX-2) in non-neoplastic and neoplastic vulvar epithelial lesions 29
Targeted therapies in gynecological cancers 29
Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients. 29
Laparoscopic sacrocolpopexy versus pelvic organ prolapse suspension for surgical management of pelvic organ prolapse: a retrospective study 29
Surveillance alone in stage I malignant ovarian germ cell tumors: a MITO (Multicenter Italian Trials in Ovarian cancer) prospective observational study 29
Clinical role of Cyclooxygenase-2 (COX-2) expression in tumor and stromal component of cervical cancer 28
Postoperative concomitant boost radiotherapy in high risk endometrial cancer 28
Risk Assessment Model for Complications in Minimally Invasive Hysterectomy: A Pilot Study 28
Prospettive future per i tumori della cervice uterina 28
Phase II study on Pemetrexed in advanced and/or recurrent cervical cancer patients: a MITO study 28
Cyclooxygenase-2 expression in lymph node metastasis of cervical and vulvar cancer 28
The peritoneal cavity: tumor metastasis and growth 28
Neoadjuvant therapy changes the lymphocyte composition of tumor-draining lymph nodes in cervical carcinoma 27
Laparoscopic versus robotic hysterectomy in obese and extremely obese patients with endometrial cancer: A multi-institutional analysis 27
COX-2 inhibition in gynaecological cancers 27
Laparoscopic en bloc right diaphragmatic peritonectomy for diaphragmatic endometriosis according to the Sugarbaker technique 27
Tamoxifen modulates the expression of Ki67, apoptosis, and microvessel density in cervical cancer 27
Verso la classificazione molecolare dei tumori: possibili implicazioni prognostiche e terapeutiche 27
Prognostic role of the ratio between cyclooxygenase-2 (COX-2) in tumor and stroma compartments in cervical cancer 27
Endometriosis and Cancer 27
Progestin-realising intrauterine device insertion plus palliative radiotherapy in frail, elderly uterine cancer patients unfit for radical treatment 27
Expression of surviving in locally advanced cervical cancer (LACC) patients administered chemoradiation (CT/RT) followed by radical surgery (RS): prediction of response and clinical outcome 27
Minimally Invasive Approaches in Locally Advanced Cervical Cancer Patients Undergoing Radical Surgery After Chemoradiotherapy: A Propensity Score Analysis 27
Il carcinoma ovarico familiare 27
Nerve-sparing laparoscopic colposacropexy using a percutaneous surgical system: a case report 26
Cyclooxygenase-2 (COX-2) expression in locally advanced cervical cancer patients undergoing chemoradiation plus surgery 26
Fattori prognostici nel carcinoma ovarico epiteliale 26
Tumori dell'ovaio 26
From bio-molecular and technology innovations to clinical practice: focus on ovarian cancer 26
New insights in biological characterization of ovarian cancer 26
Which role for pre-treatment laparoscopic staging? 26
Indicatori molecolari prognostici e predittivi di risposta nel carcinoma ovarico 26
Ovarian cancer patients with "node-positive-only" Stage IIIC disease have a more favorable outcome than Stage IIIA/B 26
Expression of cyclooxygenase-2 (COX-2) in tumour and stroma compartments in cervical cancer: clinical implications 25
Intensity-modulated extended field chemoradiation plus simultaneous integrated boost in the preoperative treatment of locally advanced cervical cancer: a dose-escalation study 25
Clinical outcome of recurrent locally advanced cervical cancer (LACC) submitted to primary multimodality therapies 25
Role of minimally invasive surgery versus open approach in patients with early-stage uterine carcinosarcomas: a retrospective multicentric study 25
Radical surgery (RS) plus intraperitoneal hyperthermic perfusion (IPHP) with oxaliplatin followed by intravenous docetaxel in the treatment of peritoneal carcinosis from platinum-sensitive recurrent ovarian cancer (OC): A pilot study 25
Proposal of a prognostic score in combined modality treatment of locally advanced carcinoma of the uterine cervix 25
Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients 25
Comparison of absorbable and permanent sutures for laparoscopic sacrocervicopexy: A randomized controlled trial 25
Laparoscopic vs transvaginal cuff closure after total laparoscopic hysterectomy: a randomized trial by the Italian Society of Gynecologic Endoscopy 25
Phase II study of oxaliplatin (OXA) and docetaxel (DTX) in recurrent ovarian cancer 24
Completion surgery after concomitant chemoradiation in obese women with locally advanced cervical cancer: Evaluation of toxicity and outcome measures 24
Simultaneous integrated boost volumetric modulated Arc therapy in the postoperative treatment of high-risk to intermediate-risk endometrial cancer: results of ADA II phase I-II trial 24
Prolonged Chemoradiation in Locally Advanced Carcinoma of the Uterine Cervix Final Results of a Phase II Study (ESTER-1) 24
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: Feasibility and clinical results 23
Survivin expression in ovarian cancer and its correlation with clinico-pathological, surgical and apoptosis-related parameters 23
Lymphocyte composition of tumor draining lymph nodes from cervical and endometrial cancer patients 23
Nuovi Fattori Biologici di Prognosi nel Carcinoma dell'Endometrio 23
Is there a prognostic role for the pattern of recurrence in platinum-sensitive relapsing ovarian cancer patients? 23
Increased cyclooxygenase-2 expression is associated with better clinical outcome in patients submitted to complete ablation for severe endometriosis 23
Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and Her-2/neu expression in ovarian cancer 22
New drugs in ovarian cancer 22
Il tumore ovarico borderline: diagnosi, trattamento, restaging 22
Squamous cell carcinoma antigen in patients with locally advanced cervical carcinoma undergoing Preoperative radiochemotherapy: Association with pathological response to treatment and clinical outcome 22
Prognostic factors in clear cell carcinoma of endometrium: analysis of 55 cases 22
Celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, modulates cytokines levels in serum of cervical cancer patients 22
Comparison Between Laparoscopic and Robotic Surgery in Elderly Patients With Endometrial Cancer: A Retrospective Multicentric Study 22
Novel VEGF-independent Strategies Targeting Tumor Vasculature: Clinical Aspects 22
Totale 2.997
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.102
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.102
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024203 0 0 0 121 9 2 0 1 24 30 4 12
2024/2025659 19 48 40 24 74 2 1 24 193 13 110 111
2025/20262.508 95 371 221 261 55 109 642 227 156 259 49 63
2026/202721 21 0 0 0 0 0 0 0 0 0 0 0
Totale 3.391